Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Baxter
Dow
Johnson and Johnson
Medtronic

Last Updated: October 2, 2022

Investigational Drug Information for Manogepix


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Manogepix?

Manogepix is an investigational drug.

There have been 4 clinical trials for Manogepix. The most recent clinical trial was a Phase 1 trial, which was initiated on September 15th 2019.

The most common disease conditions in clinical trials are Mycoses, Invasive Fungal Infections, and Infection. The leading clinical trial sponsors are Amplyx Pharmaceuticals, Pfizer, and [disabled in preview].

There is one US patent protecting this investigational drug and thirty-three international patents.

Recent Clinical Trials for Manogepix
TitleSponsorPhase
A Bioequivalence Study of APX001 High-load and Low-load TabletsPfizerPhase 1
Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare MoldsAmplyx PharmaceuticalsPhase 2
A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001Amplyx PharmaceuticalsPhase 1

See all Manogepix clinical trials

Clinical Trial Summary for Manogepix

Top disease conditions for Manogepix
Top clinical trial sponsors for Manogepix

See all Manogepix clinical trials

International Patents for Manogepix

Drugname Country Document Number Estimated Expiration Related US Patent
Manogepix Australia AU2008246798 2027-04-27 See Plans and Pricing
Manogepix Canada CA2685194 2027-04-27 See Plans and Pricing
Manogepix China CN101622251 2027-04-27 See Plans and Pricing
Manogepix China CN102702185 2027-04-27 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Baxter
Dow
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.